Arqt stock forecast.

Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.

Arqt stock forecast. Things To Know About Arqt stock forecast.

Nov 2, 2023 · After registering a 0.44% upside in the last session, Arcutis Biotherapeutics Inc (ARQT) has traded red over the past five days. The stock hit a weekly high of 2.46 this Wednesday, 11/01/23, jumping 0.44% in its intraday price action. The 5-day price performance for the stock is -5.04%, and -50.55% over 30 days. Arcutis Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARQT updated stock price target summary.Find the latest Arqit Quantum Inc. (ARQQ) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

A high-level overview of Arcutis Biotherapeutics, Inc. (ARQT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.ARQT stock had a strong performance on August 22, 2023. The 12-month price forecasts for Arcutis Biotherapeutics Inc had a median target of 44.50, with a high estimate of 57.00 and a low estimate of 22.00. This represents a significant increase of 506.27% from the last price of 7.34. The consensus among investment analysts is to buy stock in ...

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Westlake Village, California based early commercial-stage biopharmaceutical concern focused on the development of dermatological treatments in ...Arcutis Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARQT updated stock price target summary.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 51.00, with a high estimate of 140.00 and a low estimate of 18.00. Their ORCL share price targets range from $93.00 to $150.00. On average, they anticipate the company's share price to reach $124.23 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View analysts price targets for ORCL or view top-rated stocks among Wall Street analysts.

Today's Change. (-3.45%) -$0.07. Current Price. $1.96. Price as of November 27, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...

ARQT Arcutis Biotherapeutics Inc Last Close. Nov 27 • 04:00PM ET. 1.96 ... 3 Biotech Stocks With Key Catalysts Coming in December (InvestorPlace) ... Broker Revenue Forecasts For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Are Surging Higher (Simply Wall St.) Aug-11-23 06:02AM

Complete Arcutis Biotherapeutics Inc. stock information by Barron's. View real-time ARQT stock price and news, along with industry-best analysis.MARA | Complete Marathon Digital Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.18.04 -87.30% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest ARQT News | Press Releases After Plunging -35.64% in 4... 13 нояб. 2023 г. ... ARQT has risen $0.21 from the previous closing price of $1.91 on volume of 1,059,755 shares. Over the past year the S&P 500 is higher by 11.57% ...13 нояб. 2023 г. ... ARQT has risen $0.21 from the previous closing price of $1.91 on volume of 1,059,755 shares. Over the past year the S&P 500 is higher by 11.57% ...The average one-year price target for ARQT / Arcutis Biotherapeutics Inc is $11.39. The forecasts range from a low of $4.04 to a high of $21. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to ...

View Arcutis Biotherapeutics, Inc ARQT investment & stock information. Get the latest Arcutis Biotherapeutics, Inc ARQT detailed stock quotes, stock data, Real …ARQT stock had a strong performance on August 22, 2023. The 12-month price forecasts for Arcutis Biotherapeutics Inc had a median target of 44.50, with a high estimate of 57.00 and a low estimate of 22.00. This represents a significant increase of 506.27% from the last price of 7.34. The consensus among investment analysts is to buy stock in ...Find the latest Taysha Gene Therapies, Inc. (TSHA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Nov 24, 2023 · A high-level overview of Arcutis Biotherapeutics, Inc. (ARQT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 23 Wall Street research analysts have issued 12-month price targets for Snap's shares. Their SNAP share price targets range from $7.00 to $16.00. On average, they predict the company's share price to reach $10.65 in the next year. This suggests that the stock has a possible downside of 24.7%.

ARQT Stock 12 Months Forecast. $25.29. (936.48% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Arcutis Biotherapeutics in the last 3 months. …Find the latest Arqit Quantum Inc. (ARQQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Arcutis Biotherapeutics, Inc. (ARQT) delivered earnings and revenue surprises of -0.77% and 20.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for ...Arcutis has launched Zoryve, a topical cream for the treatment of psoriasis, and is focused on transitioning to a commercial-stage company. Read more about ARQT stock here.Nov 30, 2023 · Analyst Forecast According to 9 analysts, the average rating for ARQT stock is "Buy." The 12-month stock price forecast is $27.25, which is an increase of 1,380.98% from the latest price. Valuation ; FCF Yield, -12,0%, -24,1% ; Price to Book, -, 3,50x ; Nbr of stocks (in thousands), 43 566, 50 295 ; Reference price · 28,1, 20,7 ...Arcutis Biotherapeutics lowest stock price was $1.77 and its highest was $18.19 in the past 12 months. What is Arcutis Biotherapeutics’s market cap? Currently, no data AvailableStock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy.beststocks.comARQT Arcutis Biotherapeutics Inc Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)

Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Nov 6, 2023 · Analyst projections state that ARQT is forecast to be at a low of $4.00 and a high of $50.00. In order for the stock price to hit the forecast high, the stock would need to plunge -1949.18% from its current level, while the stock would need to crash -63.93% from its current level to reach the projected low.

Breaking news and in-depth coverage from the global business and financial markets. The latest corporate earnings reports from the stock market and insights into the future of digital currency.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...Arcutis is building momentum around its Zoryve segment with a string of recent advancements at the back end of FY22 and into the new year. Find out why ARQT stock is a Buy.Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals.Arcutis Biotherapeutics Stock Price, News & Analysis (NASDAQ:ARQT) $1.99 +0.15 (+8.15%) (As of 12/1/2023 ET) Compare Today's Range $1.76 $2.00 50-Day Range $1.84 $5.83 52-Week Range $1.76 $18.04 Volume 2.93 million shs Average Volume 2.67 million shs Market Capitalization $187.82 million P/E Ratio N/A Dividend Yield66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed …The consensus price target of analysts on Wall Street is $36.63, which implies an increase of 91.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $57.00 respectively. As a result, ARQT is trading at a discount of -1781.19% off the target high and -98.02% off the low.The Arcutis Biotherapeutics Inc stock price fell by -0.529% on the last day (Wednesday, 22nd Nov 2023) from $1.89 to $1.88. During the last trading day the stock fluctuated 17.51% from a day low at $1.77 to a day high of $2.08. The price has fallen in 6 of the last 10 days and is down by -14.55% for this period.

Arcutis Biotherapeutics ARQT is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here's what investors need to know before the announcement. Analysts estimate that Arcutis ...Aug 22, 2023 · ARQT stock had a strong performance on August 22, 2023. The 12-month price forecasts for Arcutis Biotherapeutics Inc had a median target of 44.50, with a high estimate of 57.00 and a low estimate of 22.00. This represents a significant increase of 506.27% from the last price of 7.34. The consensus among investment analysts is to buy stock in ... According to the data, eight analysts have offered their 12-month price forecasts for ARQT stock. The median target price is $21.00, with a high estimate of $50.00 and a low estimate of $4.00. This indicates a potential increase of 762.42% from the last recorded price of $2.44. Furthermore, the current consensus among the eight polled ...Instagram:https://instagram. option trading websitea1 edge findermutf vimaxalt stock As of May 30, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $7.81. Arcutis Biotherapeutics Inc is down 7.02% from its previous closing price of $8.40. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $8.11 and $8.57. Currently, there are 61.17 million shares of Arcutis Biotherapeutics Inc ...Arcutis Biotherapeutics GAAP EPS of -$0.73 beats by $0.15, revenue of $38.1M beats by $7.28M. SA NewsFri, Nov. 03. international reit etfc3.ai stock news EA | Complete Electronic Arts Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Zacks Industry Outlook Highlights Electronic Arts ... oz stock market Nov 3, 2023 · ARQT has an Altman Z-Score of -5.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Arcutis Biotherapeutics, Inc. (ARQT) stock, including valuation metrics, financial numbers, share information and more. Arcutis Biotherapeutics Inc Follow Share $1.90 After Hours: $1.91 (0.53%) +0.0100 Closed: Nov 29, 7:17:41 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Immunitybio Inc $3.98 IBRX1.49%...Arcutis Biotherapeutics (ARQT) stock price prediction is 1.0118522608668 USD. The Arcutis Biotherapeutics stock forecast is 1.0118522608668 USD for 2024 November 09, Saturday with technical analysis.